Tag : Lenvima

Latest News

Merck and Eisai Present First-Time Data From Two Studies Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Seven Different Tumor Types at ESMO Virtual Congress 2020

Newsemia
KENILWORTH, N.J., & WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)—- $MRK #MRK–Merck and Eisai Present First-Time Data From Two Studies Evaluating KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) in Seven...
Neurology

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Newsemia
Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy